Navigation Links
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Date:8/28/2008

ward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to receive regulatory approval for its drug candidates, Arena's ability to partner lorcaserin, APD125, APD791 or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents, the timing and receipt of payments and fees, if any, from Arena's collaborators, and Arena's ability to redeem with common stock any outstanding shares of its series B convertible preferred stock. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Contacts: Jack Lief Mary Claire Duch

President and CEO WeissComm Partners


'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
2. Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
3. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
4. ThreeWire Expands Presence in the Pharmaceutical Arena
5. Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
6. Arena Pharmaceuticals Announces First Quarter 2008 Financial Results
7. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
9. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, February 27, 2008
10. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... 17 Prometheus Research, a leading provider ... been awarded a $136,500 National Science Foundation grant ... that can be installed and configured at low ... use. ,, The National Science Foundation (NSF) awarded ... Prometheus Data Publisher, an application allowing non-technical users ...
(Date:12/17/2009)... novel stem cell based,technology of Cellonis Biotechnologies, Beijing, ... brain cancer -- of a 36 year old ... shows that the activated,immune system can directly kill ... The amazing outcome of this novel treatment within ... vaccination therapies may be,targeted towards cancer stem cell ...
(Date:12/17/2009)... Dec. 17 Reportlinker.com announces that ... in its catalogue: ,, Infectious ... http://www.reportlinker.com/p0170008/Infectious-Disease-Molecular-Diagnostic-Testing.html ,, ... clinical significance and market needs for major ... of companies developing and marketing molecular diagnostic ...
(Date:12/17/2009)... December 17 Biovista Inc.,today announced the ... access,to Biovista,s BEA literature mining platform. BEA will ... that Novus Biologicals is offering to visitors of ... allow site visitors to identify,genes that are related ... and from these browse Novus reagents that have ...
Breaking Biology Technology:Prometheus Research Awarded National Science Foundation Grant for Easy to Use, Web-Enabled Database Software 2Prometheus Research Awarded National Science Foundation Grant for Easy to Use, Web-Enabled Database Software 3For the First Time, a Glioma - Brain Cancer - may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing 2For the First Time, a Glioma - Brain Cancer - may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing 3For the First Time, a Glioma - Brain Cancer - may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing 4Reportlinker Adds Infectious Disease Molecular Diagnostic Testing 2Novus Biologicals Awards Contract to Biovista Inc. to Drive its Web-Based Novus Explorer Service 2
... 17 /PRNewswire-Asia/ -- WuXi AppTec is honored to have,Prof. ... on natural product,total synthesis, as a WuXi AppTec Science ... our company,s scientists today. Total Synthesis,is a process of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) , ...
... 17 The Healthcare and Science business of ... of the "hottest" researchers and research papers. In its ... the top 13 authors who fielded the highest numbers of ... papers of 2008."Our annual list of those authoring multiple Hot ...
... Amgen (Nasdaq: AMGN ) will present at the ... 18, 2009 at the Boston Marriott Copley Place, Boston, Mass., ... Senior Vice President of North American Commercial Operations, will present. ... Internet and can be accessed from Amgen,s Web site, ...
Other Biology Technology:Professor K. C. Nicolaou Speaks at WuXi AppTec 2Thomson Reuters Names 'Hottest' Researchers and Papers of 2007-2008 2
(Date:12/17/2009)... Dec. 17 Chiltern International Limited ... providing clinical development and staffing services in ... to announce our collaboration with Dr ... Dr Nawab Qizilbash, MBChB BSc MRCP (UK) ... OXON Epidemiology Ltd. He served as Director ...
(Date:12/17/2009)... form of progressive deafness in males has been identified ... National Institute on Deafness and Other Communication Disorders. The ... development and maintenance. The findings are published in the ... Journal of Human Genetics . , "This discovery ... M.D., Ph.D., director of the NIDCD. "Not only does ...
(Date:12/17/2009)... MO, December 17, 2009 Time and time again, ... health benefits including lowering risks associated with the comorbidities ... to lose weight meeting the National Institutes of Health ... January/February 2010 issue of the Journal of Nutrition ... an antidote for obesity and its comorbidities is exercise, ...
Breaking Biology News(10 mins):Chiltern Announces Collaboration With Dr Nawab Qizilbash 2Gene linked to a rare form of progressive hearing loss in males is identified 2Negative emotions outweigh intent to exercise at health clubs 2Prepaid Emergency Travel Announces a Unique Service That Provides Peace of Mind During Family Emergencies 53181 1Prepaid Emergency Travel Announces a Unique Service That Provides Peace of Mind During Family Emergencies 53181 2The Mills Group LLC Announces ElderCare PrimePlus Service 53178 1The Mills Group LLC Announces ElderCare PrimePlus Service 53178 2Commercial Real Estate Group of Tucson Unveils Online Tool that Quickly Informs Commercial Real Estate Tenants of Lease Options 53175 1Commercial Real Estate Group of Tucson Unveils Online Tool that Quickly Informs Commercial Real Estate Tenants of Lease Options 53175 2
... discovered that the structure of human bones is vastly ... implications for how some debilitating bone disorders are treated. ... Health Trust in Newmarket, and the BAM Federal Institute ... the characteristic toughness and stiffness of bone is predominantly ...
... Ninety-seven years after an American was hanged in London in ... British history, forensic science at Michigan State University is producing ... Crippen was hanged for murdering and dismembering his showgirl wife, ... the police in hot pursuit. Loaded with enough sordid details ...
... Agency must take a more aggressive leadership role in ... the Mississippi River and the northern Gulf of Mexico ... National Research Council. EPA has failed to use its ... state activities along the Mississippi and ensure progress toward ...
Other Biology News:New research on structure of bones raises questions for treatment of osteoporosis 2Science casts doubt on famous British murder case 2Science casts doubt on famous British murder case 3Stronger EPA leadership needed to improve water quality in Mississippi River 2Stronger EPA leadership needed to improve water quality in Mississippi River 3Stronger EPA leadership needed to improve water quality in Mississippi River 4
Mouse monoclonal [TONI-1] to Angiotensin II Type 1 Receptor (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 185 SwissProtID: P30556...
1/4" to 1/8" Adapter for Reflectance Probe Holder...
... Glucagon-like peptide-1(7-36) amide (GLP-1), C-terminal ... but shows <0.1% cross reactivity with ... or other related peptides such as ... Most mammalian species. GLP-1 is identical ...
Human/Mouse/Rat AMPK beta 1 Affinity Purified Polyclonal Ab...
Biology Products: